Diabetes, Digestive, and Kidney Diseases Extramural Research in Indiana
Diabetes, Digestive, and Kidney Diseases Extramural Research (93.847) awarded $138 million to recipients in Indiana in 145 grants from fiscal 2021 to 2025, 1.4% of the program's national total. Trustees of Indiana University received the most, $117 million.
- Awarded in Indiana$138 million
- Awards145
- Share of the program1.4%
- Rank among states20th of 51
- National total$9.6 billion
By year
| Fiscal year | Awards | Amount |
|---|---|---|
| FY 2021 | 85 | $30.4 million |
| FY 2022 | 73 | $28.0 million |
| FY 2023 | 73 | $27.0 million |
| FY 2024 | 67 | $26.8 million |
| FY 2025 | 55 | $25.4 million |
Recipients in Indiana
| Recipient | Type | Awards | Amount |
|---|---|---|---|
| Trustees of Indiana University | Colleges and universities | 117 | $117 million |
| Purdue University | Colleges and universities | 13 | $8.8 million |
| Trustees of Indiana University | Colleges and universities | 8 | $7.3 million |
| University of Notre Dame Du Lac | Colleges and universities | 2 | $2.2 million |
| Medosome Biotec LLC | Small businesses | 2 | $1.6 million |
| Monon Bioventures LLC | Small businesses | 1 | $504,770 |
| Lutheran University Association Inc | Colleges and universities | 1 | $318,554 |
| Neurodon, LLC | Small businesses | 1 | $286,348 |
Open opportunities under this program
- Single Source for the Continuation of the Caring for OutPatiEnts after Acute Kidney Injury (COPE-AKI) Scientific and Data Research Center (U01 Clinical Trial Required)
- Single Source for the Continuation of the Epidemiology of Diabetes Interventions and Complications (EDIC) Study Research Center (Collaborative U01 Clinical Trial Not Allowed)
- Single Source for the Continuation of the Physiology of the Weight Reduced State (POWERS) Study (U01- Clinical Trials Required)
- NIH Research Software Engineer (RSE) Award (R50 Clinical Trials Not Allowed)
- Intervention Research to Improve Native American Health (R01 Clinical Trial Optional)
- HEAL Initiative: Studies to Enable Analgesic Discovery (R61/R33 - Clinical Trial Not Allowed)
- Diabetes Research Centers (P30 Clinical Trial Optional)
- Silvio O. Conte Digestive Diseases Research Core Centers (P30-Clinical Trial Optional)
- Continuation of the Cardiovascular Repository for-Type 1 Diabetes (CARE-T1D) Consortium U01 (Open Competition)- Research (U01, Clinical Trial Not Allowed)
- NIH, CDC and FDA Small Business Innovation Research Grant (Parent SBIR [R43/R44] Clinical Trial Optional)
See all 64 on the program page
Questions people ask
How much Diabetes, Digestive, and Kidney Diseases Extramural Research money goes to Indiana?
$138 million from fiscal 2021 to 2025, across 145 awards. Indiana ranks 20th of 51 states and territories for this program.
Who receives Diabetes, Digestive, and Kidney Diseases Extramural Research money in Indiana?
The largest recipient is Trustees of Indiana University, with $117 million in 117 awards. Next are Purdue University and Trustees of Indiana University.
Can organizations in Indiana apply now?
Yes, 64 opportunities under this program are open or forecast on Grants.gov. Federal grants are national, so eligibility depends on the notice, not the state.
Diabetes, Digestive, and Kidney Diseases Extramural Research in other states
Other large programs in Indiana
- Grants to States for Medicaid
- Highway Planning and Construction
- Education Stabilization Fund
- National School Lunch Program
- Child Care and Development Block Grant
- Special Education Grants to States
- Children's Health Insurance Program
- Title I Grants to Local Educational Agencies
- Temporary Assistance for Needy Families
- Broadband Equity, Access, and Deployment Program